The Suffolk Times

What the loss of ALS authorization means for Greenport emergency care

The Greenport FD’s loss of authorization to provide advanced life support care has raised questions among North Fork residents.

NeuroSense: JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity

The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b ...

Experimental oral therapy PrimeC shows safety and signals of clinical benefit in ALS

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings ...